FDAnews
www.fdanews.com/articles/150954-st-jude-medical-announces-preliminary-third-party-validation-of-registry-data-for-optim-insulated-defibrillation-leads

St. Jude Medical Announces Preliminary Third-Party Validation of Registry Data for Optim-Insulated Defibrillation Leads

November 12, 2012
St. Jude Medical, a global medical device company, announced the Population Health Research Institute has completed a preliminary analysis of data received from ongoing prospective registries that monitor the performance of the Durata and Riata ST Optim implantable cardioverter defibrillator leads.
St. Jude Medical